Doravirine

CHEBI:CHEBI_747904

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2055766
generic_name
Doravirine SDI
active_ingredient_name
DORAVIRINE
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
route
ORAL
active_ingredient_strength
1 kg/kg
dosage_form
POWDER
marketing_start_date
20190711
package_marketing_start_date
11-JUL-19
labeler_name
A-S Medication Solutions
manufacturer_name
A-S Medication Solutions
product_ndc
68554-0132
spl_id
f33b260a-67df-df04-e053-2a95a90acf4e
package_ndc
68554-0132-1
package_description
1 kg in 1 DRUM (68554-0132-1)
nui
N0000009948
pharm_class_epc
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
pharm_class
Non-Nucleoside Analog [EXT]
pharm_class_moa
Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
brand_name
PIFELTRO
brand_name_base
PIFELTRO
application_number
NDA210806
unii
913P6LK81M
spl_set_id
76ce1f00-28c0-4314-bd2c-d473fe3d0970
upc
0300063069014
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class